BioSpherix manufactures the world's most advanced barrier isolators, surrounding and protecting GMP-compliant pre-clinical and clinical cell production processes. The XVIVO barrier isolator is a less expensive and more flexible alternative to cleanrooms that is in use for cell production in FDA-and Health Canada-approved clinical trials. Their Cytocentric technologic platform puts cells first to provide unbroken physiologically-relevant conditions throughout all cell incubation and handling steps. BioSherix also manufactures oxygen control equipment for research laboratories worldwide. BioSpherix brings a Total Quality Approach to cell culture for Stem Cells, Cellular Therapies, and Regenerative Medicine.

For more information contact: Alicia Henn, PhD MBA, Chief Scientific Officer

BioSpherix Barrier Isolator Optimized For Cell Therapy:

Cell Therapy Center in Jordan:

Visit Site